MedCity News -- Outgoing Medtronic (NYSE:MDT) Chief Executive Bill Hawkins is predicting only mild pain when the federal government unveils changes to the 510(k) rules governing approval for most medical devices.
MedCity News -- Outgoing Medtronic (NYSE:MDT) Chief Executive Bill Hawkins is predicting only mild pain when the federal government unveils changes to the 510(k) rules governing approval for most medical devices.
